An Open Label Trial to Investigate Macugen for the Preservation of Visual Function in Subjects With Neovascular AMD

NCT00327470 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

288

Enrollment

INDUSTRY

Sponsor class

Stopped See termination reason in detailed description.

Conditions

Age Related Macular Degeneration (AMD)
Macular Degeneration
Choroidal Neovascularization (CNV)

Interventions

DRUG: Pegaptanib Sodium 0.3 mg

Sponsor

Pfizer